tiprankstipranks
Siemens Healthineers AG Unsponsored ADR (SMMNY)
OTHER OTC:SMMNY
US Market
SMMNY
Siemens Healthineers AG Unsponsored ADR
RESEARCH TOOLSreports

Siemens Healthineers AG Unsponsored ADR (SMMNY) Ratios

4 Followers

Siemens Healthineers AG Unsponsored ADR Ratios

SMMNY's free cash flow for Q1 2026 was €0.38. For the 2026 fiscal year, SMMNY's free cash flow was decreased by € and operating cash flow was €0.13. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 1.04 1.11 1.25 1.05 1.11
Quick Ratio
 0.72 0.84 0.89 0.73 0.78
Cash Ratio
 0.16 0.15 0.23 0.12 0.12
Solvency Ratio
 0.13 0.11 0.11 0.11 0.12
Operating Cash Flow Ratio
 0.19 0.20 0.21 0.13 0.19
Short-Term Operating Cash Flow Coverage
 0.54 0.66 0.90 0.41 0.79
Net Current Asset Value
€ -11.59B€ -14.31B€ -13.36B€ -14.41B€ -15.82B
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.34 0.35 0.36 0.34
Debt-to-Equity Ratio
 0.82 0.83 0.89 0.92 0.84
Debt-to-Capital Ratio
 0.45 0.46 0.47 0.48 0.46
Long-Term Debt-to-Capital Ratio
 0.35 0.38 0.42 0.40 0.40
Financial Leverage Ratio
 2.40 2.46 2.53 2.58 2.47
Debt Service Coverage Ratio
 0.74 0.77 1.13 0.72 1.19
Interest Coverage Ratio
 8.32 8.08 6.93 8.24 25.97
Debt to Market Cap
 0.37 0.33 0.26 0.30 0.33
Interest Debt Per Share
 13.95 8.08 7.47 7.57 7.47
Net Debt to EBITDA
 2.86 3.59 3.20 3.97 3.57
Profitability Margins
Gross Profit Margin
38.44%38.63%37.87%35.56%37.47%
EBIT Margin
14.01%14.07%13.42%10.24%13.43%
EBITDA Margin
19.54%19.61%18.89%17.43%19.61%
Operating Profit Margin
14.72%14.70%14.76%11.25%14.11%
Pretax Profit Margin
12.19%12.20%11.28%8.89%12.89%
Net Profit Margin
9.10%9.17%8.68%6.96%9.39%
Continuous Operations Profit Margin
9.21%9.28%8.76%7.03%9.46%
Net Income Per EBT
74.67%75.16%76.97%78.27%72.79%
EBT Per EBIT
82.79%83.05%76.45%79.02%91.38%
Return on Assets (ROA)
4.79%3.88%4.22%3.23%4.15%
Return on Equity (ROE)
11.65%9.53%10.67%8.35%10.27%
Return on Capital Employed (ROCE)
11.20%8.69%9.57%7.34%8.27%
Return on Invested Capital (ROIC)
7.32%5.88%6.88%5.13%5.64%
Return on Tangible Assets
10.22%8.29%9.10%7.24%9.58%
Earnings Yield
5.01%3.91%3.23%2.81%4.13%
Efficiency Ratios
Receivables Turnover
 3.64 2.58 3.10 2.90 3.07
Payables Turnover
 6.70 5.01 6.54 6.34 5.86
Inventory Turnover
 3.25 3.31 3.32 3.25 3.39
Fixed Asset Turnover
 4.91 4.67 5.00 5.15 5.08
Asset Turnover
 0.53 0.42 0.49 0.46 0.44
Working Capital Turnover Ratio
 23.34 9.62 12.54 21.14 21.46
Cash Conversion Cycle
 158.36 178.89 171.53 180.63 164.28
Days of Sales Outstanding
 100.40 141.41 117.60 126.00 118.74
Days of Inventory Outstanding
 112.39 110.30 109.78 112.18 107.78
Days of Payables Outstanding
 54.44 72.83 55.85 57.55 62.24
Operating Cycle
 212.80 251.72 227.37 238.18 226.52
Cash Flow Ratios
Operating Cash Flow Per Share
 2.34 1.30 1.11 0.81 1.00
Free Cash Flow Per Share
 1.62 0.95 0.79 0.43 0.63
CapEx Per Share
 0.72 0.34 0.31 0.37 0.38
Free Cash Flow to Operating Cash Flow
 0.69 0.73 0.72 0.54 0.62
Dividend Paid and CapEx Coverage Ratio
 1.39 1.64 1.40 0.95 1.25
Capital Expenditure Coverage Ratio
 3.23 3.77 3.55 2.16 2.65
Operating Cash Flow Coverage Ratio
 0.17 0.16 0.15 0.11 0.14
Operating Cash Flow to Sales Ratio
 0.11 0.13 0.11 0.08 0.10
Free Cash Flow Yield
4.27%4.13%2.95%1.81%2.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.93 25.55 30.93 35.53 24.20
Price-to-Sales (P/S) Ratio
 1.72 2.34 2.69 2.47 2.27
Price-to-Book (P/B) Ratio
 2.18 2.44 3.30 2.97 2.49
Price-to-Free Cash Flow (P/FCF) Ratio
 22.24 24.19 33.88 55.22 35.13
Price-to-Operating Cash Flow Ratio
 15.35 17.77 24.33 29.64 21.86
Price-to-Earnings Growth (PEG) Ratio
 -18.08 7.41 1.07 -1.38 1.52
Price-to-Fair Value
 2.18 2.44 3.30 2.97 2.49
Enterprise Value Multiple
 11.68 15.54 17.42 18.17 15.15
Enterprise Value
 55.32B 67.16B 73.59B 68.63B 64.53B
EV to EBITDA
 12.15 15.54 17.42 18.17 15.15
EV to Sales
 2.37 3.05 3.29 3.17 2.97
EV to Free Cash Flow
 30.65 31.46 41.51 70.68 45.96
EV to Operating Cash Flow
 21.16 23.11 29.81 37.94 28.60
Tangible Book Value Per Share
 -4.52 -2.91 -2.90 -3.44 -3.53
Shareholders’ Equity Per Share
 16.50 9.46 8.15 8.08 8.83
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.22 0.21 0.27
Revenue Per Share
 20.86 9.84 10.02 9.68 9.67
Net Income Per Share
 1.90 0.90 0.87 0.67 0.91
Tax Burden
 0.75 0.75 0.77 0.78 0.73
Interest Burden
 0.87 0.87 0.84 0.87 0.96
Research & Development to Revenue
 0.08 0.08 0.09 0.09 0.08
SG&A to Revenue
 0.15 0.16 0.15 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.23 1.44 1.27 1.20 1.11
Currency in EUR